bz-423 has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hartley, JA; Hazrati, A; Hursthouse, MB; Kotha, AK; Male, L; Motukuri, M; Rathnam, RP; Richardson, SC; Spencer, J | 1 |
1 other study(ies) available for bz-423 and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Synthesis of a 1,4-benzodiazepine containing palladacycle with in vitro anticancer and cathepsin B activity.
Topics: Animals; Antineoplastic Agents; Benzodiazepines; Cathepsin B; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chlorocebus aethiops; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Palladium; Vero Cells | 2009 |